Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lachlan Webb

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|August 21, 2020
Liver Function Test Abnormalities in Experimental and Clinical <i>Plasmodium vivax</i> InfectionAnand Odedra, Lachlan Webb, Louise Marquart, et al.
NEJM Evidence|February 6, 2024
Tetrahydrocannabinol and Cannabidiol in Tourette SyndromePhilip E Mosley, Lachlan Webb, Anastasia Suraev, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 27, 2025
Altered striatal functional gradients in obsessive-compulsive disorderLachlan Webb, Luke Hearne, Ye E Tian, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Distinct cognitive and functional connectivity features from healthy cohorts can identify clinical obsessive-compulsive disorderLuke J Hearne, B T Thomas Yeo, Lachlan Webb, et al.
Molecular Psychiatry|December 14, 2025
Distinct cognitive and functional connectivity features from healthy cohorts can identify clinical obsessive-compulsive disorderLuke J Hearne, B T Thomas Yeo, Lachlan Webb, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Plos Medicine|August 22, 2020
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in AustraliaRebecca E Watts, Anand Odedra, Louise Marquart, et al.
BMC Medicine|November 28, 2024
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malariaAzrin N Abd-Rahman, Daniel Kaschek, Anne Kümmel, et al.
Cell Reports. Medicine|December 30, 2020
Th2-like T Follicular Helper Cells Promote Functional Antibody Production during <i>Plasmodium falciparum</i> InfectionJo-Anne Chan, Jessica R Loughland, Fabian de Labastida Rivera, et al.
Nature Immunology|May 20, 2020
Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malariaRahul Vijay, Jenna J Guthmiller, Alexandria J Sturtz, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|August 21, 2020
Liver Function Test Abnormalities in Experimental and Clinical <i>Plasmodium vivax</i> InfectionAnand Odedra, Lachlan Webb, Louise Marquart, et al.
NEJM Evidence|February 6, 2024
Tetrahydrocannabinol and Cannabidiol in Tourette SyndromePhilip E Mosley, Lachlan Webb, Anastasia Suraev, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 27, 2025
Altered striatal functional gradients in obsessive-compulsive disorderLachlan Webb, Luke Hearne, Ye E Tian, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Distinct cognitive and functional connectivity features from healthy cohorts can identify clinical obsessive-compulsive disorderLuke J Hearne, B T Thomas Yeo, Lachlan Webb, et al.
Molecular Psychiatry|December 14, 2025
Distinct cognitive and functional connectivity features from healthy cohorts can identify clinical obsessive-compulsive disorderLuke J Hearne, B T Thomas Yeo, Lachlan Webb, et al.
The Lancet. Infectious Diseases|October 29, 2021
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection studyJames S McCarthy, Özkan Yalkinoglu, Anand Odedra, et al.
Plos Medicine|August 22, 2020
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in AustraliaRebecca E Watts, Anand Odedra, Louise Marquart, et al.
BMC Medicine|November 28, 2024
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malariaAzrin N Abd-Rahman, Daniel Kaschek, Anne Kümmel, et al.
Cell Reports. Medicine|December 30, 2020
Th2-like T Follicular Helper Cells Promote Functional Antibody Production during <i>Plasmodium falciparum</i> InfectionJo-Anne Chan, Jessica R Loughland, Fabian de Labastida Rivera, et al.
Nature Immunology|May 20, 2020
Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malariaRahul Vijay, Jenna J Guthmiller, Alexandria J Sturtz, et al.
Pageof 4